2,638
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Chitosan-dipotassium orthophosphate lyophilizate: a novel in situ thermogel carrier system of allogeneic platelet lysate growth factors

, , &
Pages 413-426 | Received 22 Nov 2021, Accepted 10 Jan 2022, Published online: 31 Jan 2022

References

  • Cao W, Krishnan S, pee. Ricci MS, et al. (2013). Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies. Eur J Pharm Biopharm 85:287–93.
  • Amable PR, Bizon R, Carias V, et al. (2013). Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4:67.
  • Anitua E, Alkhraisat MH, Orive G. (2012). Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 157:29–38.
  • Anitua E, MD DDS, de la Fuente M, et al. (2015). Preservation of biological activity of plasma and platelet-derived eye drops after their different time and temperature conditions of storage. Cornea 34:1144–8., http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=ovftq&NEWS=N&AN=00003226-201509000-00026.
  • Anitua E, Muruzabal F, Pino A, et al. (2013). Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea 32:1380–6.
  • Assegehegn G, Brito-de la Fuente E, Franco JM, Gallegos C. (2020). Use of a temperature ramp approach (TRA) to design an optimum and robust freeze-drying process for pharmaceutical formulations. Int J Pharm 578:119116.
  • Awotwe-Otoo D, Agarabi C, Wu GK, et al. (2012). Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Int J Pharm 438:167–75.,.
  • Belk JW, Kraeutler MJ, Houck DA, et al. (2021). Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med 49:249–60.
  • Bernal-Chávez SA, Alcalá-Alcalá S, Cerecedo D, Ganem-Rondero A. (2020). Platelet lysate-loaded PLGA nanoparticles in a thermo-responsive hydrogel intended for the treatment of wounds. Eur J Pharm Sci 146:105231.
  • Bhattarai N, Ramay HR, Gunn J, et al. (2005). PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Control Release 103:609–24.
  • Bjelošević M, Zvonar Pobirk A, Planinšek O, Ahlin Grabnar P. (2020). Excipients in freeze-dried biopharmaceuticals: Contributions toward formulation stability and lyophilisation cycle optimisation. Int J Pharm 576:119029.
  • Bullock AJ, Garcia M, Shepherd J, et al. (2020). Bacteria induced pH changes in tissue-engineered human skin detected non-invasively using Raman confocal spectroscopy. Appl Spectrosc Rev 55:158–71.
  • Carter MJ, Fylling CP. (2011). Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 11:e38.
  • Casettari L, Cespi M, Palmieri GF, Bonacucina G. (2013). Characterization of the interaction between chitosan and inorganic sodium phosphates by means of rheological and optical microscopy studies. Carbohydr Polym 91:597–602.
  • Censi R, Casadidio C, Deng S, et al. (2020). Interpenetrating hydrogel networks enhance mechanical stability, rheological properties, release behavior and adhesiveness of platelet-rich plasma. IJMS 21:1399.
  • Chahla J, Cinque ME, Piuzzi NS, et al. (2017). A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 99:1769–79.
  • Cheng G, Ma X, Li J, et al. (2018). Incorporating platelet-rich plasma into coaxial electrospun nanofibers for bone tissue engineering. Int J Pharm 547:656–66.
  • Chenite A, Chaput C, Wang D, et al. (2000). Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21:2155–61.
  • Drinnan CT, Zhang G, Alexander MA, et al. (2010). Multimodal release of transforming growth factor-β1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J Control Release 147:180–6.
  • Fekete N, Gadelorge MÉL, Rst DFÜ, et al. (2012). Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14:540–54.
  • Fernandez-Moure JS, Van Eps JL, Cabrera FJ, et al. (2017). Platelet-rich plasma: a biomimetic approach to enhancement of surgical wound healing. J Surg Res 207:33–44.
  • Grasmeijer N, Stankovic M, De Waard H, et al. (2013). Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled system. Biochim Biophys Acta - Proteins Proteomics 1834:763–9.
  • Haeuser C, Goldbach P, Huwyler J, et al. (2020). Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations. Eur J Pharm Biopharm 147:45–56.,.
  • Hansen LJJ, Daoussi R, Vervaet C, et al. (2015). Freeze-drying of live virus vaccines: a review. Vaccine 33:5507–19.,.
  • He M, Guo X, Li T, et al. (2020). Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers. Cell Transplant 29:963689720931428–9.
  • Higuchi T. (1963). Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9.
  • Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface and agitation: III—experimental procedure in study of agitation. Ind Eng Chem 23:1160–8.
  • Horn J, Schanda J, Friess W. (2018). Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates. Eur J Pharm Biopharm 127:342–54.
  • Jain E, Chinzei N, Blanco A, et al. (2019). Platelet-rich plasma released from polyethylene glycol hydrogels exerts beneficial effects on human chondrocytes. J Orthop Res 37:2401–10.,.
  • Jain E, Sheth S, Dunn A, et al. (2017). Sustained release of multicomponent platelet-rich plasma proteins from hydrolytically degradable PEG hydrogels. J Biomed Mater Res A 105:3304–14.
  • Jena S, Krishna Kumar NS, Aksan A, Suryanarayanan R. (2019). Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility. Int J Pharm 569:118568.
  • Kieb M, Sander F, Prinz C, et al. (2017). Platelet-rich plasma powder: a new preparation method for the standardization of growth factor concentrations. Am J Sports Med 45:954–60.,.
  • Korsmeyer RW, Gurny R, Doelker E, et al. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35.(83)90064-9.
  • Kumar L, Chandrababu KB, Balakrishnan SM, et al. (2019). Optimizing the Formulation and Lyophilization Process for a Fragment Antigen Binding (Fab) Protein Using Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry (ssHDX-MS). Mol Pharmaceutics 16:4485–95.,.
  • Langenbucher F. (1972). Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol 24:979–81.
  • Lavertu M, Filion D, Buschmann MD. (2008). Heat-induced transfer of protons from chitosan to glycerol phosphate produces chitosan precipitation and gelation. Biomacromolecules 9:640–50.
  • Lee JK, Kim DB, Il Kim J, Kim PY. (2000). In vitro cytotoxicity tests on cultured human skin fibroblasts to predict skin irritation potential of surfactants. Toxicol. Vitr 14:345–9.(00)00028-X.
  • Lewis LM, Johnson RE, Oldroyd ME, et al. (2010). Characterizing the freeze-drying behavior of model protein formulations. AAPS Pharm Sci Tech 11:1580–90.
  • Li XY, Kong XY, Zhang J, et al. (2011). A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids. J Pharm Sci 100:232–41.,.
  • Liu L, Gao Q, Lu X, Zhou H. (2016). In situ forming hydrogels based on chitosan for. Asian J Pharm Sci 11:673–83.
  • Marx RED. (2001). Platelet-Rich Plasma (PRP): What is PRP and what is not PRP? Implant Dent 10:225–8.
  • Mendyk A, Jachowicz R, Fijorek K, et al. (2012). KinetDS: an open source software for dissolution test data analysis. Dissolution Technol 19:6–11.
  • Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. (2017). How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions. Eur J Pharm Biopharm 114:288–95.
  • Murayama K, Tomida M. (2004). Heat-induced secondary structure and conformation change of bovine serum albumin investigated by Fourier transform infrared spectroscopy. Biochemistry 43:11526–32.
  • Nair LS, Starnes T, Ko JWK, Laurencin CT. (2007). Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules 8:3779–85.
  • Oneto P, Etulain J, Oneto P, Etulain J. (2021). PRP in wound healing applications PRP in wound healing applications. Platelets 32:189–11.
  • Rathore N, Rajan RS. (2008). Current perspectives on stability of protein drug products during formulation, fill and finish operations. Biotechnol Prog 24:504–14.
  • Remmele RL, Krishnan S, Callahan WJ. (2012). Development of Stable Lyophilized Protein Drug Products. Curr Pharm Biotechnol 13:471–96.
  • Rodrigues MA, Rego P, Geraldes V, et al. (2021). Mannitol crystallization at sub-zero temperatures: time/temperature-resolved synchrotron X-ray diffraction study and the phase diagram. J Phys Chem Lett 12:1453–60.,.
  • Rossi S, Faccendini A, Bonferoni MC, et al. (2013). “Sponge-like” dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Int J Pharm 440:207–15.
  • Ruel-Gariépy E, Chenite A, Chaput C, et al. (2000). Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 203:89–98.,(00)00428-2.
  • Santana H, Sotolongo J, González Y, et al. (2014). Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying. Biologicals 42:322–33.
  • Schallmoser K, Strunk D. (2009). Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp 32:1523.
  • Sellberg F, Berglund E, Ronaghi M, et al. (2016). Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units. Transfus Apher Sci 55:333–7.
  • Stodolak-Zych E, Jeleń P, Dzierzkowska E, et al. (2020). Modification of chitosan fibers with short peptides as a model of synthetic extracellular matrix. J Mol Struct 1211:128061.
  • Strandberg G, Sellberg F, Sommar P, et al. (2017). Standardizing the freeze-thaw preparation of growth factors from platelet lysate. EDITORIAL 57:1058–7.,.
  • Sumner SM, Naskou MC, Thoresen M, et al. (2017). Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors. J AAB Tranfusion 57:1755–62.
  • Sundman EA, Cole BJ, Fortier LA, et al. (2011). Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39:2135–40.
  • Ta HT, Han H, Larson I, et al. (2009). Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system. Int J Pharm 371:134–41.
  • U.S. Department of Health and Human Services Food and Drug Administration (2009). ICH Q8(R2) Pharmaceutical Development. Work Qual by Des. Pharm 8:28.,
  • Wu G, Yuan Y, He J, et al. (2016). Stable thermosensitive in situ gel-forming systems based on the lyophilizate of chitosan/α,β-glycerophosphate salts. Int J Pharm 511:560–9.